Sudarshan Chemical Industries Limited has informed the Exchange about Investor Presentation
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Chemical shared its Q3 FY26 investor presentation covering the integration of the acquired Heubach group under the 'One Sudarshan' umbrella. Consolidated Q3 FY26 revenue stood at ₹2,387 Cr (vs ₹2,103 Cr in Q3 FY25), but the company reported weak profitability with PBT of just ₹6 Cr (vs ₹5 Cr in Q3 FY25) and a 9M FY26 consolidated loss before exceptional items of ₹-138 Cr. The acquired Heubach group posted a Q3 adjusted EBITDA loss of ₹-38 Cr, driven by continued destocking, low demand, price reductions, and a one-time ₹46 Cr hit from the new labour code. Management cut FY26 Business EBITDA guidance for the acquired group to ~€16 Mn (from earlier €25 Mn) but projects recovery to €90-100 Mn by FY28/29.
Near-term picture is challenging with margin pressure, losses in the acquired business, and elevated net debt of ₹1,123 Cr. However, management's cost-saving initiatives (₹40 Cr fixed cost savings already captured) and longer-term EBITDA recovery targets could support the stock once destocking ends. Short-term sentiment may remain cautious given the guidance cut.